Androgen receptor antagonists for prostate cancer therapy

C Helsen, T Van den Broeck, A Voet… - Endocrine-related …, 2014 - erc.bioscientifica.com
Medullary thyroid carcinomas (MTC) arise from thyroid parafollicular, calcitonin-producing C-
cells and can occur either as sporadic or as hereditary diseases in the context of familial …

[HTML][HTML] GDNF and the RET receptor in cancer: new insights and therapeutic potential

LM Mulligan - Frontiers in physiology, 2019 - frontiersin.org
The Glial cell line-derived neurotrophic Family Ligands (GFL) are soluble neurotrophic
factors that are required for development of multiple human tissues, but which are also …

A phase I study of cabozantinib (XL184) in patients with differentiated thyroid cancer

ME Cabanillas, MS Brose, J Holland, KC Ferguson… - Thyroid, 2014 - liebertpub.com
Background: Cabozantinib targets tyrosine kinases including MET, vascular endothelial
growth factor (VEGF) receptor 2, and rearranged during transfection (RET). Differentiated …

ALK and RET inhibitors promote HLA class I antigen presentation and unmask new antigens within the tumor immunopeptidome

CY Oh, MG Klatt, C Bourne, T Dao, MM Dacek… - Cancer immunology …, 2019 - AACR
T-cell immunotherapies are often thwarted by the limited presentation of tumor-specific
antigens abetted by the downregulation of human leukocyte antigen (HLA). We showed that …

The Iodine Rush: Over- or Under-Iodination Risk in the Prophylactic Use of Iodine for Thyroid Blocking in the Event of a Nuclear Disaster

V Calcaterra, C Mameli, V Rossi, G Massini… - Frontiers in …, 2022 - frontiersin.org
Iodine is an essential element for the production of thyroid hormones (THs). Both deficient
and excess iodine intakes may precipitate in adverse thyroidal events. Radioactive iodine …

BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma

AU Bastos, G Oler, BHN Nozima… - European Journal of …, 2015 - academic.oup.com
Background Thyroid cancer incidence has dramatically increased worldwide over the last
two decades. The rise is mostly due to an increased detection of small papillary thyroid …

Indoleamine 2, 3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment

S Moretti, E Menicali, P Voce, S Morelli… - The Journal of …, 2014 - academic.oup.com
Context: Indoleamine 2, 3-dioxygenase 1 (IDO1) is a single chain oxidoreductase that
catalyzes tryptophan degradation to kynurenine. In cancer, it appears to exert an …

ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population

AU Bastos, AC de Jesus… - European journal of …, 2018 - academic.oup.com
Objective PTC-specific analysis identified novel fusions involving RET, BRAF, NTRK1,
NTRK3, AGK and ALK genes in adults and pediatric PTCs. Although many novel fusions are …

Radiation-induced thyroid cancers: Overview of molecular signatures

K Suzuki, V Saenko, S Yamashita, N Mitsutake - Cancers, 2019 - mdpi.com
Enormous amounts of childhood thyroid cancers, mostly childhood papillary thyroid
carcinomas (PTCs), after the Chernobyl nuclear power plant accident have revealed a …

[HTML][HTML] Inflammatory mediators, tumor necrosis factor-α and interferon-γ, induce EMT in human PTC cell lines

N Lv, Y Gao, H Guan, D Wu, S Ding… - Oncology …, 2015 - spandidos-publications.com
Inflammatory mediators, tumor necrosis factor (TNF)-α and interferon (IFN)-γ, promote
adverse outcomes in numerous types of cancer; however, their role in papillary thyroid …